Jump to main content
Jump to site search

Issue 3, 2019
Previous Article Next Article

Cyclic iRGD peptide as a dual-functional on–off gatekeeper of mesoporous nanocontainers for targeting NRP-1 and selective drug release triggered by conformational conversion

Author affiliations

Abstract

Adopting conformational conversion of a peptide as a trigger to control on–off gatekeeping on the surface of mesoporous silica nanoparticles has several advantages. Here, we designed a dual-functional cyclic peptide with an iRGD sequence as a stimulus-responsive on–off gatekeeper on the surface of mesoporous silica nanocontainers. The cyclic peptide gatekeeper with an intramolecular disulfide bond between the two cysteine units at both terminals of the peptide sequence exhibited selective drug release triggered by stimulus-induced conformational conversion. Furthermore, the iRGD sequence of the cyclic peptide gatekeeper enhanced the intracellular uptake and therapeutic efficacy of the nanoparticles by specifically binding with NRP-1 receptor on the surface of target cancer cells.

Graphical abstract: Cyclic iRGD peptide as a dual-functional on–off gatekeeper of mesoporous nanocontainers for targeting NRP-1 and selective drug release triggered by conformational conversion

Back to tab navigation

Supplementary files

Publication details

The article was received on 12 Sep 2018, accepted on 05 Dec 2018 and first published on 06 Dec 2018


Article type: Paper
DOI: 10.1039/C8NJ04649B
Citation: New J. Chem., 2019,43, 1517-1522
  •   Request permissions

    Cyclic iRGD peptide as a dual-functional on–off gatekeeper of mesoporous nanocontainers for targeting NRP-1 and selective drug release triggered by conformational conversion

    J. Lee, E. Oh, J. Lee, T. Kang, H. G. Kim, H. Kang, H. J. Park and C. Kim, New J. Chem., 2019, 43, 1517
    DOI: 10.1039/C8NJ04649B

Search articles by author

Spotlight

Advertisements